← SynDRA
DROPERIDOL
SynDRA canonical compound SYN0003759 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | DRD2 |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
All known targets
- DRD2
- DRD4
- DRD3
- HTR2A
- HTR1A
- SCN2A
- SCN1A
- Pgrmc1
- KCNH2
- Htr1a
- HTR4
- HTR2C
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- DRD2 ANTAGONIST
- D2-like dopamine receptor antagonist
- DRD3 ANTAGONIST
- DRD4 ANTAGONIST
- DRD2 BINDER
Drug classes
- Adjuvants, Anesthesia
- Antiemetics
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Dopamine Agents
- Dopamine Antagonists
- Dopamine D2 Receptor Antagonists
- Gastrointestinal Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Psychotropic Drugs
ATC classes
Cross-references
Synonyms
- dehydrobenzperidol
- droleptan
- inapsin
- inapsine
- neurolidol
- MCN-JR-4749
- NSC-169874
- R-4749
- Dridol
- Droleptan
- Droperidol component of innovar
- Inapsine
- DHBP
- Dehidrobenzperidol
- Dehydrobenzoperidol
- Dehydrobenzperidol
- Deidrobenzperidolo
- Dihidrobenzperidol
- Droperidolo
- Droperidolum
- Halkan
- Inappin
- Inapsin
- Innovan
- Inopsin
- Inoval
- Leptanal
- Leptofen
- Properidol
- Sintodril
- Sintosian
- Thalamanol
- Thalamonal
- Vetkalm
- Component of Innovar
- Droperidolo [DCIT]
- Janssen Brand of Droperidol
- Kern Brand of Droperidol
Look up DROPERIDOL in the interactive SynDRA portal →